Inhalant Abuse

Overview

Journal Paediatr Child Health

Publisher Oxford University Press

Specialty Pediatrics

Date 2011 Sep 3

PMID 21886449

Citations 10

Authors

L Baydala

Affiliations

Soon will be listed here.

Abstract

Inhalant abuse - also known as volatile substance abuse, solvent abuse, sniffing, huffing and bagging - is the deliberate inhalation of a volatile substance to achieve an altered mental state. Inhalant abuse is a worldwide problem that is especially common in individuals from minority and marginalized populations, and is strongly correlated with the social determinants of health. It often affects younger children, compared with other forms of substance abuse, and crosses social and ethnic boundaries. Inhalants are pharmacologically diverse products that are selected for their low price, legal and widespread availability, and ability to rapidly induce euphoria. Chronic abuse is associated with serious and often irreversible effects. Widespread screening and early referrals to treatment programs have resulted in significant improvements in the mental, physical and social conditions of those affected. The present statement reviews critical aspects of inhalant abuse, highlighting new information and data that pertain to Aboriginal children and youth, and provides recommendations for treatment and prevention.

Citing Articles

The Need for Action: Addressing Inhalant Abuse and Whitener Addiction Among Adolescents.

Chandrakar R, Srivastav S, Babhulkar V, Gupta S, Agrawal S, Jaiswal A Cureus. 2023; 15(6):e40339.

PMID: 37456429 PMC: 10338889. DOI: 10.7759/cureus.40339.

Respiratory health and its determinants among Nunavimmiut: results from the Qanuilirpitaa? 2017 Nunavik Health Survey.

Robert P, Levesque B, Bourbeau J, Khan F, Boulet L, Dube M Can J Public Health. 2023; 115(Suppl 1):136-151.

PMID: 36624337 PMC: 10830964. DOI: 10.17269/s41997-022-00722-9.

All in a scent - naphthalene dependence confined to pregnancy: a case report.

Wimalasiri I, Suraweera C BMC Psychiatry. 2022; 22(1):723.

PMID: 36403047 PMC: 9675229. DOI: 10.1186/s12888-022-04369-1.

A scoping review of school-based indigenous substance use prevention in preteens (7-13 years).

Maina G, Mclean M, Mcharo S, Kennedy M, Djiometio J, King A Subst Abuse Treat Prev Policy. 2020; 15(1):74.

PMID: 32998753 PMC: 7528230. DOI: 10.1186/s13011-020-00314-1.

Inhaled Solvent Abuse Mimicking Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Thulasirajah S, Michaud J, Doja A, McMillan H Child Neurol Open. 2020; 7:2329048X20934914.

PMID: 32613026 PMC: 7307582. DOI: 10.1177/2329048X20934914.

References

Ridenour T . Inhalants: not to be taken lightly anymore. Curr Opin Psychiatry. 2006; 18(3):243-7. DOI: 10.1097/01.yco.0000165593.52811.cd. View

Broussard L . The role of the laboratory in detecting inhalant abuse. Clin Lab Sci. 2001; 13(4):205-9. View

Kulig J . Tobacco, alcohol, and other drugs: the role of the pediatrician in prevention, identification, and management of substance abuse. Pediatrics. 2005; 115(3):816-21. DOI: 10.1542/peds.2004-2841. View

Sakai J, Hall S, Mikulich-Gilbertson S, Crowley T . Inhalant use, abuse, and dependence among adolescent patients: commonly comorbid problems. J Am Acad Child Adolesc Psychiatry. 2004; 43(9):1080-8. DOI: 10.1097/01.chi.0000132813.44664.64. View

Albright J, Lebovitz B, Lipson R, LUFT J . Upper aerodigestive tract frostbite complicating volatile substance abuse. Int J Pediatr Otorhinolaryngol. 1999; 49(1):63-7. DOI: 10.1016/s0165-5876(99)00009-9. View

Spiller H . Epidemiology of volatile substance abuse (VSA) cases reported to US poison centers. Am J Drug Alcohol Abuse. 2004; 30(1):155-65. DOI: 10.1081/ada-120029871. View

Lorenc J . Inhalant abuse in the pediatric population: a persistent challenge. Curr Opin Pediatr. 2003; 15(2):204-9. DOI: 10.1097/00008480-200304000-00012. View

Jaffe S . Treatment and relapse prevention for adolescent substance abuse. Pediatr Clin North Am. 2002; 49(2):345-52, vi. DOI: 10.1016/s0031-3955(01)00008-6. View

Meadows R, Verghese A . Medical complications of glue sniffing. South Med J. 1996; 89(5):455-62. DOI: 10.1097/00007611-199605000-00001. View

10.

Leslie K . Youth substance use and abuse: challenges and strategies for identification and intervention. CMAJ. 2008; 178(2):145-8. PMC: 2175001. DOI: 10.1503/cmaj.071410. View

11.

Toumbourou J, Stockwell T, Neighbors C, Marlatt G, Sturge J, Rehm J . Interventions to reduce harm associated with adolescent substance use. Lancet. 2007; 369(9570):1391-1401. DOI: 10.1016/S0140-6736(07)60369-9. View

12.

Plested B, Beauvais F . Treatment strategies for volatile solvent abusers in the United States. NIDA Res Monogr. 1995; 148:250-9. View

13.

Tenenbein M, Casiro O, Seshia M, Debooy V . Neonatal withdrawal from maternal volatile substance abuse. Arch Dis Child Fetal Neonatal Ed. 1996; 74(3):F204-7. PMC: 2528344. DOI: 10.1136/fn.74.3.f204. View

14.

Wu L, Ringwalt C . Inhalant use and disorders among adults in the United States. Drug Alcohol Depend. 2006; 85(1):1-11. PMC: 1592311. DOI: 10.1016/j.drugalcdep.2006.01.017. View

15.

Romanelli F, Smith K, Thornton A, Pomeroy C . Poppers: epidemiology and clinical management of inhaled nitrite abuse. Pharmacotherapy. 2004; 24(1):69-78. DOI: 10.1592/phco.24.1.69.34801. View

16.

Perron B, Howard M . Perceived risk of harm and intentions of future inhalant use among adolescent inhalant users. Drug Alcohol Depend. 2008; 97(1-2):185-9. PMC: 2554669. DOI: 10.1016/j.drugalcdep.2008.04.005. View

17.

Crocetti M . Inhalants. Pediatr Rev. 2008; 29(1):33-4. DOI: 10.1542/pir.29-1-33. View

18.

Jones H, Balster R . Inhalant abuse in pregnancy. Obstet Gynecol Clin North Am. 1998; 25(1):153-67. DOI: 10.1016/s0889-8545(05)70363-6. View

19.

Medina-Mora M, Real T . Epidemiology of inhalant use. Curr Opin Psychiatry. 2008; 21(3):247-51. DOI: 10.1097/YCO.0b013e3282fc9875. View

20.

Rinsky R . Benzene and leukemia: an epidemiologic risk assessment. Environ Health Perspect. 1989; 82:189-91. PMC: 1568103. DOI: 10.1289/ehp.8982189. View